Unity Biotechnology, Inc.UBXNASDAQ
Loading
Analyst Sentiment
Analysts lean bullish — 70% recommend buying.
Consensus Rating
Buy
10 analysts·Moderate coverage
70%
Rating Distribution
Strong Buy
00%
Buy
770%
Hold
330%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 1149% higher.
Bear Case
$1.00
+400%
Consensus
$2.50
+1149%
Bull Case
$4.00
+1899%
Price Range10 analysts
Low
Consensus
High
$1.00
$4.00
Current Target
Current Price
$0.20
Upside to Target
$2.30
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.